However, SOX2 suppression may be permissive for a sub-set of gastric cancers with CDX2 induction to acquire mutations in epigenetic modifier genes, including ARID1A, KMT2D, KMT2C, KMT2A, and KMT2B. The gene discussed is CDX2; the disease is gastric cancer.